Ensrud KE, Crandall CJ. Osteoporosis. Ann Intern Med. 2017;167(3):ITC17–32. https://doi.org/10.7326/AITC201708010.

Article  PubMed  Google Scholar 

Collaborators GBDF. Global, regional, and national burden of bone fractures in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet Healthy Longev. 2021;2(9):e580–92. https://doi.org/10.1016/S2666-7568(21)00172-0.

Article  Google Scholar 

Sing CW, Lin TC, Bartholomew S, Bell JS, Bennett C, Beyene K, et al. Global epidemiology of hip fractures: secular trends in incidence rate, post-fracture treatment, and all-cause mortality. J Bone Miner Res. 2023;38(8):1064–75. https://doi.org/10.1002/jbmr.4821.

Article  PubMed  Google Scholar 

Martel-Pelletier J, Barr AJ, Cicuttini FM, Conaghan PG, Cooper C, Goldring MB, et al. Osteoarthritis. Nat Rev Dis Primers. 2016;2:16072. https://doi.org/10.1038/nrdp.2016.72.

Article  PubMed  Google Scholar 

Collaborators GBDO. Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023;5(9):e508–22. https://doi.org/10.1016/S2665-9913(23)00163-7.

Article  Google Scholar 

Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019;393(10191):2636–46. https://doi.org/10.1016/S0140-6736(19)31138-9.

Article  PubMed  Google Scholar 

Petermann-Rocha F, Balntzi V, Gray SR, Lara J, Ho FK, Pell JP, et al. Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2022;13(1):86–99. https://doi.org/10.1002/jcsm.12783.

Article  PubMed  Google Scholar 

Kirk B, Cawthon PM, Arai H, Avila-Funes JA, Barazzoni R, Bhasin S, et al. The conceptual definition of sarcopenia: delphi consensus from the Global Leadership Initiative in Sarcopenia (GLIS). Age Ageing. 2024. https://doi.org/10.1093/ageing/afae052.

Article  PubMed  PubMed Central  Google Scholar 

Patterson SD, Aebersold RH. Proteomics: the first decade and beyond. Nat Genet. 2003;33(3):311–23. https://doi.org/10.1038/ng1106.

Article  PubMed  CAS  Google Scholar 

Zheng J, Haberland V, Baird D, Walker V, Haycock PC, Hurle MR, et al. Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases. Nat Genet. 2020;52(10):1122–31. https://doi.org/10.1038/s41588-020-0682-6.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009;361(8):756–65. https://doi.org/10.1056/NEJMoa0809493.

Article  PubMed  CAS  Google Scholar 

Nakamura T, Matsumoto T, Sugimoto T, Hosoi T, Miki T, Gorai I, et al. Clinical trials express: fracture risk reduction with denosumab in Japanese postmenopausal women and men with osteoporosis: denosumab fracture intervention randomized placebo controlled trial (DIRECT). J Clin Endocrinol Metab. 2014;99(7):2599–607. https://doi.org/10.1210/jc.2013-4175.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cosman F, Crittenden DB, Adachi JD, Binkley N, Czerwinski E, Ferrari S, et al. Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med. 2016;375(16):1532–43. https://doi.org/10.1056/NEJMoa1607948.

Article  PubMed  CAS  Google Scholar 

Saag KG, Petersen J, Brandi ML, Karaplis AC, Lorentzon M, Thomas T, et al. Romosozumab or alendronate for fracture prevention in women with osteoporosis. N Engl J Med. 2017;377(15):1417–27. https://doi.org/10.1056/NEJMoa1708322.

Article  PubMed  CAS  Google Scholar 

Hochberg MC, Guermazi A, Guehring H, Aydemir A, Wax S, Fleuranceau-Morel P, et al. Effect of intra-articular Sprifermin vs placebo on femorotibial joint cartilage thickness in patients with osteoarthritis: the FORWARD randomized clinical trial. JAMA. 2019;322(14):1360–70. https://doi.org/10.1001/jama.2019.14735.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Rooks D, Swan T, Goswami B, Filosa LA, Bunte O, Panchaud N, et al. Bimagrumab vs optimized standard of care for treatment of sarcopenia in community-dwelling older adults: a randomized clinical trial. JAMA Netw Open. 2020;3(10):e2020836. https://doi.org/10.1001/jamanetworkopen.2020.20836.

Article  PubMed  PubMed Central  Google Scholar 

Hay M, Thomas DW, Craighead JL, Economides C, Rosenthal J. Clinical development success rates for investigational drugs. Nat Biotechnol. 2014;32(1):40–51. https://doi.org/10.1038/nbt.2786.

Article  PubMed  CAS  Google Scholar 

Topol EJ. The revolution in high-throughput proteomics and AI. Science. 2024;385(6716):eads5749. https://doi.org/10.1126/science.ads5749.

Article  PubMed  Google Scholar 

Fredriksson S, Gullberg M, Jarvius J, Olsson C, Pietras K, Gustafsdottir SM, et al. Protein detection using proximity-dependent DNA ligation assays. Nat Biotechnol. 2002;20(5):473–7. https://doi.org/10.1038/nbt0502-473.

Article  PubMed  CAS  Google Scholar 

Lundberg M, Eriksson A, Tran B, Assarsson E, Fredriksson S. Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood. Nucleic Acids Res. 2011;39(15):e102. https://doi.org/10.1093/nar/gkr424.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gold L, Ayers D, Bertino J, Bock C, Bock A, Brody EN, et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS ONE. 2010;5(12):e15004. https://doi.org/10.1371/journal.pone.0015004.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Uffelmann E, Huang QQ, Munung NS, de Vries J, Okada Y, Martin AR, et al. Genome-wide association studies. Nat Rev Methods Primers. 2021;1(1):59. https://doi.org/10.1038/s43586-021-00056-9.

Article  CAS  Google Scholar 

Kachuri L, Chatterjee N, Hirbo J, Schaid DJ, Martin I, Kullo IJ, et al. Principles and methods for transferring polygenic risk scores across global populations. Nat Rev Genet. 2024;25(1):8–25. https://doi.org/10.1038/s41576-023-00637-2.

Article  PubMed  CAS  Google Scholar 

Ferkingstad E, Sulem P, Atlason BA, Sveinbjornsson G, Magnusson MI, Styrmisdottir EL, et al. Large-scale integration of the plasma proteome with genetics and disease. Nat Genet. 2021;53(12):1712–21. https://doi.org/10.1038/s41588-021-00978-w.

Article  PubMed  CAS  Google Scholar 

Zhao JH, Stacey D, Eriksson N, Macdonald-Dunlop E, Hedman AK, Kalnapenkis A, et al. Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets. Nat Immunol. 2023;24(9):1540–51. https://doi.org/10.1038/s41590-023-01588-w.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sanderson E, Glymour MM, Holmes MV, Kang H, Morrison J, Munafo MR, et al. Mendelian randomization. Nat Rev Methods Primers. 2022. https://doi.org/10.1038/s43586-021-00092-5.

Article  PubMed  PubMed Central  Google Scholar 

Zheng J, Maerz W, Gergei I, Kleber M, Drechsler C, Wanner C, et al. Mendelian randomization analysis reveals a causal influence of circulating sclerostin levels on bone mineral density and fractures. J Bone Miner Res. 2019;34(10):1824–36. https://doi.org/10.1002/jbmr.3803.

Article  PubMed  CAS  Google Scholar 

Yoshiji S, Butler-Laporte G, Lu T, Willett JDS, Su CY, Nakanishi T, et al. Proteome-wide Mendelian randomization implicates nephronectin as an actionable mediator of the effect of obesity on COVID-19 severity. Nat Metab. 2023;5(2):248–64. https://doi.org/10.1038/s42255-023-00742-w.

Article  PubMed  PubMed Central  CAS